Table 7 Characteristics of trials evaluating IDM programmes in primary care or home-based setting
| Â | RECODE | Rea 2004 | Boxall 2005 | Fernandez 2009 | Wetering 2010 | Gottlieb 2011 |
|---|---|---|---|---|---|---|
Recruitment | P | P + S | P + S | S | S | P |
Pilot study | + | - | - | - | - | - |
Population | GOLD stage 1-4 | GOLD stage 1-4 | GOLD 4 | GOLD 4 | GOLD 2-3 | GOLD 2 |
Intervention | Multidisciplinary team training, designing practice and patient relevant treatment plans including education, smoking cessation, physiotherapeutic reactivation, dietary intervention (24 mo) | Exacerbation action plan, structured follow-up by nurse, GP. Education about smoking cessation, medication (12 mo) | Home rehabilitation programma (12 wks), under supervision of physiotherapist. Educational sessions for patients and carers, including structured follow up by physiotherapists, nurses, occupational therapy | Home-rehabilitation programme (11 mo) under supervision of physiotherapist. Three education sessions | Intensive exercise programme (4mo), individualized education programme, smoking cessation, dietary intervention (if needed). 20mo maintenance phase, exercise at home (under supervision). | Intensive exercise and educational programme (7wks) led by multidisciplinary team. Smoking cessation counseling. |
Included HCP | 3-5 | 3 | 3 | 2 | 3 | ? |
Randomization | Clustered | Clustered | Individual | Individual | Individual | Individual |
Blinding outcome assessor | + | - | - | - | + | - |
Stratification/matching | + | - | - | - | - | - |
Powercalculation based on | MRC score >2 | Hospital days | 6MWD | Not mentioned | SGRQ | Not mentioned |
Cost-effectiveness analysis | + | - | - | - | + | - |
Included patients | 1086 | 135 | 60 | 50 | 199 | 61 |
Follow-up (months) | 24 | 12 | 3 | 12 | 24 | 18 |